← Leaderboards
Konstantin Ichtchenko
New York University School Of Medicine
$13,868,176
Attributed
$17,200,360
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,200,360 · 4
By mechanism
R01$13,369,949 · 2
U01$3,382,270 · 1
R21$448,141 · 1
Top collaborators
- Eric A. Johnson6 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Susan B Zolla-Pazner$26,881,465
- Kam-Meng Tchou-Wong$3,861,790
- George Foltin$21,006
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsTraffickingCytosolMotor NeuronsAntidotesToxic EffectMolecularLightPoisoningBotulinumCytoplasmSpecificityPhysiologicalAffectPre-ClinicalBotulismIntoxicationIn VitroMetalloproteasesCessation Of LifeNovel Therapeutic InterventionImmunoglobulin TherapyProductionRecovery
Grant awards (19)
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$953,298
R01 · FY2025 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$980,692
R01 · FY2024 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$987,063
R01 · FY2023 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,033,776
R01 · FY2022 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.$1,132,082
U01 · FY2021 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.$1,127,378
U01 · FY2020 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.$1,122,810
U01 · FY2019 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.$1,118,376
R01 · FY2018 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.$1,183,570
R01 · FY2017 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2016 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2015 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,164,124
R01 · FY2013 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$403,485
R01 · FY2013 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2012 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,381,473
R01 · FY2011 · AI · contact PI
Botulinum Neurotoxin Derivatives for Targeted Neuronal Delivery$241,005
R21 · FY2008 · AI · contact PI
Botulinum Neurotoxin Derivatives for Targeted Neuronal Delivery$207,136
R21 · FY2007 · AI · contact PI
CIRL RECEPTOR FAMILY AND SECRETION$227,720
R01 · FY2001 · GM
CIRL RECEPTOR FAMILY AND SECRETION$221,085
R01 · FY2000 · GM